Kinnunen Kati, Kalesnykas Giedrius, Mähönen Anssi J, Laidinen Svetlana, Holma Liisa, Heikura Tommi, Airenne Kari, Uusitalo Hannu, Ylä-Herttuala Seppo
Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland.
J Gene Med. 2009 May;11(5):382-9. doi: 10.1002/jgm.1311.
The present study aimed to determine the efficiency and safety of baculovirus-mediated intravitreal gene transfer in rabbit eye and to compare its efficiency with adenovirus. We also studied how an intravitreal injection of vectors producing vascular endothelial growth factor D (VEGF-D) impacts the vasculature of rabbit eye.
Baculoviral (BacVEGF-D) or adenoviral VEGF-D (AdVEGF-D) were administered intravitreally into the right eye at different doses (10(8), 10(9) and 10(10) IU/ml) to 24 animals. Left eyes were injected with control viruses. To determine how long transgene expression lasted, we injected BacVEGF-D or BacLacZ to the vitreous humour of 11 animals and followed them for 4 weeks. Vitreous samples were taken after sacrifice for enzyme-linked immunosorbent assays and eyes were removed and fixed for histological analyses.
Both baculoviruses and adenoviruses caused efficient expression of VEGF-D in the rabbit eyes. BacVEGF-D caused a dose-dependent vascular leakage and a moderate dilation of the capillaries. The highest effect was seen 6 days after gene transfer and was detectable for 2 weeks. Intravitreal injection of baculovirus caused expression of VEGF-D in the inner retina, photoreceptor cells and in retinal pigment epithelium cells, whereas adenovirus-mediated VEGF-D expression was detected in the nerve fiber layer and ganglion cell layer. Baculovirus caused a transient inflammation similar to adenoviruses.
The study suggests that baculoviruses are efficient vectors for ocular gene transfer, especially if deeper retinal layers need to be transduced. In addition, intravitreal VEGF-D gene transfer caused blood-retina barrier breakdown but not neovessel formation in the rabbit eye.
本研究旨在确定杆状病毒介导的玻璃体内基因转移在兔眼中的有效性和安全性,并将其有效性与腺病毒进行比较。我们还研究了玻璃体内注射产生血管内皮生长因子D(VEGF-D)的载体如何影响兔眼的脉管系统。
将杆状病毒(BacVEGF-D)或腺病毒VEGF-D(AdVEGF-D)以不同剂量(10⁸、10⁹和10¹⁰ IU/ml)玻璃体内注射到24只动物的右眼。左眼注射对照病毒。为了确定转基因表达持续的时间,我们向11只动物的玻璃体内注射BacVEGF-D或BacLacZ,并对它们进行4周的跟踪观察。处死动物后采集玻璃体样本进行酶联免疫吸附测定,并摘除眼球进行组织学分析。
杆状病毒和腺病毒均可在兔眼中有效表达VEGF-D。BacVEGF-D引起剂量依赖性的血管渗漏和毛细血管中度扩张。基因转移后6天观察到最高效应,且可持续检测2周。玻璃体内注射杆状病毒导致VEGF-D在内层视网膜、光感受器细胞和视网膜色素上皮细胞中表达,而腺病毒介导的VEGF-D表达则在神经纤维层和神经节细胞层中检测到。杆状病毒引起的炎症与腺病毒相似,呈一过性。
该研究表明杆状病毒是眼部基因转移的有效载体,尤其是在需要转导视网膜深层时。此外,玻璃体内VEGF-D基因转移导致兔眼血视网膜屏障破坏,但未形成新生血管。